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Abstract
Patient-specific verification of intensity-modulated radiation therapy (IMRT) plans
can be done by dosimetric measurements or by independent dose or monitor unit
calculations. The aim of this study was the clinical evaluation of IMRT verifica-
tion based on a fast Monte Carlo (MC) program with regard to possible benefits
compared to commonly used film dosimetry.
25 head-and-neck IMRT plans were recalculated by a pencil beam based treat-
ment planning system (TPS) using an appropriate quality assurance (QA) phan-
tom. All plans were verified both by film and diode dosimetry and compared to
MC simulations. The irradiated films, the results of diode measurements and the
computed dose distributions were evaluated, and the data were compared on the
basis of gamma maps and dose-difference histograms.
Average deviations in the high-dose region between diode measurements and point
dose calculations performed with the TPS and MC program were 0.7 ± 2.7% and
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1.2± 3.1%, respectively. For film measurements, the mean gamma values with 3%
dose difference and 3mm distance-to-agreement were 0.74±0.28 (TPS as reference)
with dose deviations up to 10%. Corresponding values were significantly reduced
to 0.34± 0.09 for MC dose calculation. The total time needed for both verification
procedures is comparable, however, by far less labor intensive in the case of MC
simulations.
The presented study showed that independent dose calculation verification of
IMRT plans with a fast MC program has the potential to eclipse film dosimetry
more and more in the near future. Thus, the linac-specific QA part will necessarily
become more important. In combination with MC simulations and due to the simple
set-up, point-dose measurements for dosimetric plausibility checks are recommended
at least in the IMRT introduction phase.
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1 Introduction
The intensity-modulated radiotherapy (IMRT) technique is currently the most
advanced form of conformal radiotherapy and holds great promise for im-
proving radiotherapy both through increased tumor control probability and
decreased treatment toxicity. As with all treatment modalities, verification
and characterization measurements are required before clinically implementing
IMRT. Moreover, it is apparent that comprehensive quality assurance (QA) is
essential for IMRT due to the non-intuitive nature of treatment planning. Rec-
∗ Corresponding author.
Email address: thomas.goetzfried@klinik.uni-regensburg.de (Thomas
Goetzfried).
2
ommendations and guidelines for determining the appropriate use of IMRT,
beginning an IMRT program, and maintaining the adequate QA to safely use
IMRT are given in recently published and national regulatory reports [1–4].
Each institution’s QA program should be designed to encompass the entire
IMRT process, i.e. commissioning and validation of the dose calculation algo-
rithm, data transfer from the treatment planning system (TPS) to the linac
verify and record (V&R) system, and the delivery process itself. After gaining
experience, the IMRT QA is usually subdivided into a multileaf collimator
(MLC)/linac-specific QA part and a patient-specific QA part. Both parts are
parallel procedures and do not interfere directly [5]. When going this way,
patient-specific verification of IMRT plans can be done by dosimetric mea-
surements or by independent dose or MU calculations.
Dosimetric measurements typically comprise two types of checks for pre-treat-
ment QA: single-beam verification and total-plan verification. In both cases,
the patient’s IMRT plan is transferred to a phantom and calculations are done
at the points or depths of interest. Due to the characteristics of IMRT dose
distributions including complex 3D treatment volume geometries, the precise
characterization of these distributions using only point dosimeters is not prac-
tical. Mainly a comparison of two-dimensional calculated and measured data is
performed. As a two-dimensional integrating dosimetry medium, radiographic
films (an EDR-2 in particular) [6,7] or less commonly, radiochromic films [8]
are nearly ideal for such measurements due to their very good resolution.
Nevertheless, a multitude of alternative methods for patient dose validation,
e.g. large scale 2D ion chamber or diode arrays as well as flat-panel electronic
portal imaging devices (EPID) have been studied [9–11]. However, perhaps be-
cause of its familiarity and apparent simplicity, radiographic film remains one
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of the most common means for validating patient IMRT treatments through
dose measurements. The use of radiographic films for dosimetry is described
in detail in the AAPM Report 69 [12].
Methods based on Monte Carlo (MC) algorithms have been used for external
beam radiotherapy dose calculation [13]. It is well accepted that MC is the
most accurate dose calculation method, since it can precisely model realistic
radiation transport through the accelerator treatment head, the MLC and the
patient anatomy. Accordingly, MC has been regarded as a powerful tool to
obtain the accurate dose distributions in the (heterogeneous) patient. Efforts
have been made to implement MC in clinical treatment planning and plan
verification [14], and suitable TPS are currently put on the market. There have
been several fast MC codes developed, such as VMC/XVMC [15,16], DPM
[17], MCV [18] or MCDOSE [19]. These codes employ a variety of variance
reduction techniques and achieve reduced CPU time compared to ordinary
EGSnrc calculations. Prior to clinical use, however, the calculation method
should be commissioned against phantom measurements and the treatment
planning system algorithm.
The aim of this work was to investigate potential advantages of replacing the
quasi-3D verification with EDR-2 film dosimetry in (hybrid) phantoms by MC
dose calculation. Within the present study, 25 head-and-neck IMRT plans have
been evaluated both by experimental methods and by MC simulations. The
evaluations have been performed with regard to the time investment for both
procedures as well as the accuracy compared to the applied algorithm of the
TPS.
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2 Methods and materials
2.1 IMRT treatment plans
Plans for 25 patients with head-and-neck cancer receiving step-and-shoot
IMRT with a Siemens Primus R© linear accelerator (1 cm projected leaf width
at the isocenter distance and 6MV photons) were used in the study. IMRT
plans were based on a uniformly distributed seven-field arrangement except
for two plans which had five fields, and were optimized with Oncentra R© Mas-
terPlan (v1.5, Nucletron). The number of segments per beam varied between
4 and 15 with a total number per plan between 48 and 80 and a minimum
field size for one segment of 4 cm2. The total number of monitor units applied
per plan were between 470 and 1287 with an average of 844.
2.2 Monte Carlo simulations
The Monte Carlo simulations were performed using XVMC [20], into which
the VEF model [21] is implemented in conjunction with geometry parameters
for the patient-dependent portion of the treatment head (MLC and jaws).
Since the commissioning procedure of this model is based on standard mea-
surements in air but only on one depth dose in water for a reference field size,
additional measurements in water were carried out to verify the model and its
parameters. Percentage depth dose curves for standard field sizes and beam
profiles in various depths were compared [22]. As an example, Figure 1 repre-
sents measured and calculated depth dose curves and profiles in water for a
6MV 5× 5 cm2 photon beam of a Siemens Primus R© linac. The reference dose
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calibration is also consistent within 1%. Only minor differences were found in
output factor measurements (up to 5% for small fields).
XVMC/VEFM was used for forward calculations of all beam segments, as
obtained by the pencil beam based IMRT treatment plans and transferred via
DICOM-RT. The workflow has been previously described in detail [23]. The
dose calculations were performed with up to 128× 128 voxels (per slice). The
size of a voxel varied from 0.2 cm in transversal plane to 0.5 cm in craniocaudal
direction. The 1σ statistical uncertainty in the dose was chosen to be 1-2% of
the dose maximum Dmax.
2.3 Verification procedures
After an IMRT treatment plan was accepted, it was recalculated using iden-
tical beam settings but replacing the patient with a cylindrical polyethylene
(PE) phantom (diameter 20 cm, height 20 cm). Such a phantom is easily ac-
cessible to dosimetry by radiographic films and point measurements [7]. It is
possible to mark the coordinate system onto the films with a guided needle for
data correlation and evaluation with IMRT software (PTW-VeriSoft R© v3.0).
Similar to the procedure of Ref. [24], a seven-step dose calibration (0.5, ...,
4.0Gy) with field sizes of 10× 3 cm2 at a depth of 10 cm of RW3 was applied
within one automatic sequence of the V&R system (PrimeviewTM & Lantis R©,
Siemens) that exposes all fields to one film. As film and/or film processing
changes with time, it is important to integrate the film calibration procedure
into each film dosimetric investigation. The calibration procedure includes a
non-linear fit of the optical density vs. dose data. An approach without the
necessity of calibrating films before each IMRT verification measurement is
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reported in Ref. [25] by introducing normalized sensitometric curves and thus
verifying IMRT plans in a relative manner. Although the stability of these
curves with time and different film batches is very good, the authors recom-
mend to check the shape of the sensitometric curve at regular intervals as part
of the QA program, especially when new film batches or chemicals are used.
Additional determination of the absolute dose in a dose reference point was
done using a semiconductor diode (PTW-60008) with an effective measuring
volume of 1.1mm in diameter and 2.5µm in thickness. For diode calibration
the above mentioned cylindrical PE phantom along with a 0.3 cc rigid stem
ionization chamber (PTW-30016) as reference detector were used. The cali-
bration factor was determined in IMRT reference conditions (SSD 90 cm, field
size of 5 × 5 cm2 at isocenter and gantry angle of 0◦). Due to the similarity
of IMRT verification and calibration situations, no additional correction fac-
tors needed to be measured. The patient plan was copied onto the verification
phantom in such a way that the diode was located in a high-dose region with
no or just a small dose gradient (< 6%cm−1). The procedure was repeated for
all 25 IMRT plans included in this study. The absolute dose value was used
to correct the film dose data in order to yield absolute 2D dose distributions.
For comparison with MC simulations, the dose distribution obtained from for-
ward calculation was imported into the VeriSoft R© software. Imported planes,
i.e. dose distributions, are (automatically) resampled to a common pixel spac-
ing of 0.5mm. On the basis of dose profiles and gamma maps [26], dose dis-
tributions of film dosimetry and MC simulations, respectively, vs. TPS dose
calculation have been analyzed. Furthermore, difference matrices on a pixel-
by-pixel basis have been evaluated. Since this method is less helpful, if inhomo-
geneous dose distributions have to be examined, we focused on the high-dose
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region, i.e. between 1Gy and Dmax, in a transversal plane in proximity to the
isocenter of the phantom.
3 Results
The IMRT phantom plans were verified with EDR-2 type films, and forward-
calculation was carried out with the MC program. Average deviations in the
high-dose region between diode measurements and point dose calculations
performed with the TPS and MC program were 0.7 ± 2.7% and 1.2 ± 3.1%,
respectively. These deviations correspond to 1.2 ± 4.8 cGy and 2.0 ± 5.0 cGy
per fraction. Film and MC dose distributions were then compared using the
gamma evaluation method with 3% (local) dose difference and 3mm distance-
to-agreement as acceptance criteria. For this purpose, dose distributions ob-
tained through the PB algorithm of the TPS were used as reference, as this
algorithm is still the most frequently applied in clinical practice. The mean
gamma values were 0.74±0.28 and 0.34±0.09 for film dosimetry and MC dose
calculation, respectively, and 28.1± 20.3% and 3.5± 4.5% of all dose points
were larger than 1. The latter values reduce to 6.3 ± 5.8% and 1.2 ± 1.8%,
respectively, if only the high-dose region, i.e. between 1Gy and Dmax, is con-
sidered.
Figure 2 shows typical results of line dose calculations and measurements for
one representative case. The dose profiles were calculated in a plane close to
the isocenter and covered points up to 8 cm from the center of the phantom. In
the inset, the high-dose region is bordered by a dash-dotted line representing
the 1Gy isodose. The deviations of film and MC calculation in the high-dose
region compared to the PB calculated IMRT plan are visualized in histograms
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of the differences on a pixel-by-pixel basis (Figure 3). The results demonstrate
a pronounced broadening for film measurement data up to 10% with mean D
of -1.4% and 1σ of 2.3% (relating to the prescribed dose of 2.0Gy). However,
as mentioned above, in average only about 6% of all dose values (in the high-
dose region) fail the gamma index criteria (3% / 3mm). For this reason, the
film broadening may be attributed mainly to a small error in positioning the
phantom on the linac couch or in placing the film within the phantom. For MC
simulations, the standard deviation of 1.1% or 2.2 cGy is significantly smaller.
The key histogram parameters for all 25 IMRT plans are illustrated in Figure 4.
Except for two film verification measurements, the mean dose deviations re-
main within a confidence limit of 5% proposed for treatment plan acceptance
[24]. Additionally, the highlighted region in the figure marks the range for the
MC dose calculation results. Table 1 summarizes absolute and relative dose
deviations of MC simulations and film dosimetry. The standard deviation be-
tween TPS PB calculations and film measurements, which reflect the variance
of the 25 plans, was around 6 cGy for the mean dose values in the high-dose
area, whereas for MC calculations the deviation was less than 2 cGy. In anal-
ogy, the corresponding key histogram parameters based on the comparison
between MC dose calculation and film dosimetry can be deduced yielding to
an average deviation of 1.7% (relating to the prescribed dose) for the mean
dose value with a variance of σ2 = 0.001.
Figure 5 demonstrates the total time needed for dosimetry with point detectors
or films as well as for an independent dose calculation with XVMC/VEFM.
The time for the individual steps of each procedure is based on the present
verification study of 25 head-and-neck IMRT plans. The MC calculation re-
quired about 1 - 3 h on a single Pentium IV 2.4GHz PC depending on the
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number of segments and their sizes. While the average measuring time at the
linac for both experimental methods was about 45 minutes each, film dosime-
try was more comprehensive, doubling the total time compared to point-dose
measurements.
4 Discussion
QA in IMRT is mainly founded on quantitative comparisons between com-
puted and/or measured dose distributions. Current work on verification dose
calculations for QA purposes focused on a comparison of the commonly prac-
ticed film dosimetry with an independent dose calculation by means of MC
methods. Differences between measurement and calculation are principally
caused by an error in planning, positioning, delivery or measurement tech-
nique. An agreement between the two distributions, on the contrary, is in
itself not a proof of satisfying quality. Admittedly, the distributions that are
compared may both contain uncertainty or bias, in such way that an agreement
may be reached by chance. This consideration may serve as an argument to
include many degrees of freedom, i.e., many measuring points, in the compar-
ison. This means that comparing dose distributions is better than comparing
doses measured in a limited set of points. Although a multitude of methods
can be used for patient-specific dose based QA, individual treatment plans
must be checked using time-effective and simple methods, realizing that this
QA workload is proportional to the number of patients.
Regarding film dosimetry, there are several challenges in obtaining high-quality
dosimetric results, namely, the dependence of optical density on photon energy,
field size, depth, film batch sensitivity differences, film orientation, processing
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conditions, and scanner performance [7,12]. Based on film measurement re-
sults obtained in this study, an aimed confidence limit of 3% dose deviation
(with respect to the prescribed dose) or 6 cGy, as suggested in Ref. [27], was
only fulfilled for 16 out of 25 IMRT cases in the high-dose region. A significant
lower uncertainty and dose deviation of less than 3% for all plans compared to
the PB based TPS could be achieved when applying verification calculations
with XVMC/VEFM; however, there were still slight differences. It is strik-
ing that the TPS with its PB algorithm had a tendency to overestimate the
dose in the high dose area calculated with the MC program. These deviations
may be attributed to computational uncertainty of the PB algorithm and to
limitations in the accuracy of calculations at field edges and out of field [28].
In addition, discrepancies in output factor measurements for small fields up
to 5% for MC, and similar accuracy for PB calculations in a water phan-
tom might be taken into consideration. Same uncertainties have to be kept
in mind when comparing MC calculated dose distribution to film measure-
ments. In addition to the challenge in context to correct film dosimetry, these
difficulties contribute to the observed deviations between MC and film dose
distributions. Comparing MC and TPS PB with film dosimetry, the variance
in dose difference (σ2 = 0.001), however, is very similar for both comparisons.
As commonly known, Monte Carlo simulations are proven to be the gold stan-
dard in radiation dose calculation. Nevertheless, there are a few aspects that
need careful consideration.
While the total time for MC simulations is comparable to film dosimetry, no
extra time on the linac is required. Moreover, the manpower requirements for
MC dose calculation are reduced to the DICOM file export from the TPS
and import into the MC program. Verification calculations though will not
11
detect errors in the IMRT delivery process. For this reason, independent cal-
culations in addition to measurements of single dose points should be part of
a rigorous control of the dose delivery system. However, it is to be noted that
there are also other promising approaches, e.g. the log file based Monte Carlo
simulations [29]. The authors suggest to use this method as an initial IMRT
QA procedure to screen the plans, and the measurement based methods as a
second procedure only when necessary.
Independent dose calculations (and dosimetric measurements) are typically
performed in a homogeneous verification phantom. Hence, the influence of in-
homogeneities present in the patient is not taken into account. Several studies,
however, have shown the limitations of PB algorithms in heterogeneous media
[30,31]. The PB algorithm produces large errors for the dose in the vicinity of
interfaces and within low-density regions. In contrast, XVMC/VEFM calcula-
tions are very close to measurements even in the low-density area [31], which
may be important when calculating dose to inhomogeneous volumes such as
the head-and-neck region studied in this work. Further research is needed to
investigate these effects on the dose distribution in the (heterogeneous) patient
and to make use of MC simulations as verification tool based on the patient
CT data set.
5 Conclusion
One should keep clearly in mind that dosimetric measurements are time-
consuming and only verify the dose in a phantom geometry. Discrepancies
between planar measurements and calculations may be difficult to interpret
in terms of the clinical significance on a patient-by-patient basis. Independent
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monitor unit or dose calculations offer an alternative to dose measurements.
Monte Carlo is becoming fast enough to be used in clinics with the capa-
bility of accurate dose computations [32–35]. Once a calculation method is
properly verified, significant time can be saved when compared to measure-
ments. However, additional QA checks are needed to verify accurate transfer
of patient data and accurate delivery. Thus, a more stringent machine and
MLC QA needs to be considered. In this context, deficiency inevitably lead
to differences between calculated and measured dose distributions. As men-
tioned in the introduction, dosimetric plausibility checks in terms of point-dose
measurements are considered appropriate. Dose calculation inaccuracies due
to use of approximation algorithms like pencil beam or collapsed cone can
potentially be detected by MC simulations of the treatment plan in the pa-
tient itself instead of in a homogeneous phantom. The 3D dose verification
procedure dealing with this issue is currently under investigation and will be
reported.
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Table 1
Mean and standard (absolute and relative) dose deviations in the high-dose region
(between 1Gy and Dmax) for 25 IMRT phantom plans. Results obtained with the
pencil beam algorithm of the TPS were used as reference for comparison to film
measurements and Monte Carlo calculations.
Absolute deviation (cGy) Relating to prescribed dose (%)
Film 0.3± 5.7 0.2± 3.0
MC −2.7± 1.4 −1.4± 0.7
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Fig. 1. Measured (solid lines) compared to calculated (symbols) depth dose curves
in water for a 6MV 5×5 cm2 photon beam of a Siemens PrimusR© linear accelerator.
In the inset, the respective profiles in x direction at 5 and 20 cm depths in water
are shown.
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Fig. 2. Line dose profiles for a representative pencil beam based IMRT plan verified
by film dosimetry and MC forward calculation. The inset illustrates the dose distri-
bution and the position of the line verification. The dash-dotted lines (both figures)
represent the lower limit of the high-dose region.
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Fig. 3. Dose-difference histograms derived from the difference between film dosime-
try and MC simulations, respectively, and the PB dose calculation performed
with the treatment planning system (in the high-dose region). The dose difference
D(film/MC) - DPB is normalized to the prescribed dose of the PB plan.
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Fig. 4. Results of film verification measurements and MC forward calculations for
all 25 IMRT plans, shown as mean dose values and respective standard deviation
obtained from dose-difference histograms (see also Figure 3). The two dash-dotted
lines denote a confidence limit of 5%, the highlighted region marks the range for
MC dose calculation results.
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calculation of IMRT plans, including preparation and postprocessing. The time for
the individual steps is based on the present verification study of 25 head-and-neck
IMRT plans.
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